L, R., C, S., MB, v. H., H, M., AH, A., JF, O., . . . WFP, v. H. (2024). Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma. Head and neck pathology, 18(1), 92. https://doi.org/10.1007/s12105-024-01704-8
Chicago Style (17th ed.) CitationL, Robinson, Smit C, van Heerden MB, Moolla H, Afrogheh AH, Opperman JF, Ambele MA, and van Heerden WFP. "Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma." Head and Neck Pathology 18, no. 1 (2024): 92. https://doi.org/10.1007/s12105-024-01704-8.
MLA (9th ed.) CitationL, Robinson, et al. "Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma." Head and Neck Pathology, vol. 18, no. 1, 2024, p. 92, https://doi.org/10.1007/s12105-024-01704-8.